Ligand Pharmaceuticals (LGND) Invested Capital (2011 - 2024)
Ligand Pharmaceuticals (LGND) posted Invested Capital of $73000.0 for Q4 2024, up 180.77% sequentially from $26000.0 in Q4 2023, and up 180.77% YoY from $26000.0 in Q1 2024.
Ligand Pharmaceuticals (LGND) Invested Capital (2011 - 2024) Analysis & Trends
Ligand Pharmaceuticals has reported Invested Capital for 12 years, with the latest figure at $73000.0 in Q4 2024.
- Quarterly Invested Capital rose 180.77% year-over-year to $73000.0 in Q4 2024, while the trailing twelve-month figure through Sep 2025 was $73000.0 (up 180.77% YoY) and the FY2024 annual result came in at $73000.0, up 180.77% from the prior year.
- Invested Capital advanced to $73000.0 in Q4 2024 per LGND's latest filing, from $26000.0 in the prior quarter.
- Over five years, Invested Capital peaked at $115.0 million in Q2 2022 and troughed at $26000.0 in Q4 2023.
- A 5-year average of $34.4 million and a median of $3.4 million in 2020 frame the typical range for Invested Capital.
- The sharpest annual moves came in 2021 and 2024: Invested Capital plunged 98.45% in 2021, then jumped 180.77% in 2024.
- Over 5 years, Invested Capital stood at $6.7 million in 2020, then slumped by 98.45% to $104000.0 in 2021, then sank by 51.92% to $50000.0 in 2022, then sank by 48.0% to $26000.0 in 2023, then surged by 180.77% to $73000.0 in 2024.
- According to Business Quant data, Invested Capital over the past three periods registered $73000.0, $26000.0, and $76.8 million for Q4 2024, Q4 2023, and Q1 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 190.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.57 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 380.00 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Ligand Pharmaceuticals | 5.87 Bn | 4.51 Bn | 60.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 73,000.00 |
| Dec 31, 2023 | 26,000.00 |
| Mar 31, 2023 | 76.79 Mn |
| Dec 31, 2022 | 50,000.00 |
| Sep 30, 2022 | 76.60 Mn |
| Jun 30, 2022 | 114.97 Mn |
| Dec 31, 2021 | 104,000.00 |
| Dec 31, 2020 | 6.71 Mn |
| Jun 30, 2019 | 27.09 Mn |
| Mar 31, 2019 | 26.76 Mn |
| Dec 31, 2018 | 26.43 Mn |
| Sep 30, 2018 | 213.14 Mn |
| Jun 30, 2018 | 210.37 Mn |
| Mar 31, 2018 | 227.55 Mn |
| Dec 31, 2017 | 224.53 Mn |
| Sep 30, 2017 | 221.56 Mn |
| Jun 30, 2017 | 218.63 Mn |
| Mar 31, 2017 | 215.75 Mn |
| Dec 31, 2016 | 212.91 Mn |
| Jun 30, 2016 | 207.36 Mn |